Physician profile
John M Bormes
NPI 1578568978
$3,214.95
in general payments reported to CMS, 2019-2025
15 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,066 · 2020: $76.22 · 2021: $28.87 · 2022: $83.25 · 2023: $271 · 2024: $101 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864 · Entertainment: $97.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.59 |
| Entertainment | $97.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,206.22 | 2019-2025 | Healon Duet Pro |
| Abbvie INC. | $173.98 | 2022-2025 | Alphagan P, Lumigan |
| The Cameron-Ehlen Group, INC. | $171.52 | 2019-2023 | Tecnis Iol, Tecnis Simplicity, Healon Pro |
| Alcon Vision LLC | $142.74 | 2022-2025 | Clareon, Centurion, Hydrus Microstent |
| Optos, INC. | $97.49 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Genentech USA, INC. | $96.30 | 2022-2025 | Vabysmo, Lucentis |
| Rayner Intraocular Lenses Limited | $81.65 | 2023-2025 | Omidria, Rayone Emv, Rayone Aspheric |
| Amgen INC. | $64.71 | 2025 | Tepezza |
| Harrow Eye, LLC | $50.51 | 2023-2024 | Iheezo |
| Regeneron Healthcare Solutions, INC. | $39.02 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $27.33 | 2023 | Syfovre |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Ocular Therapeutix, INC. | $19.14 | 2025 | Dextenza |
| Chiesi USA, INC. | $13.94 | 2019 | |
| Allergan, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bormes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.